Intensive Walking Therapy for Stroke Rehabilitation
(VIEWS-2 Trial)
Trial Summary
What is the purpose of this trial?
The proposed research will evaluate the individual and combined effects of task-specificity and intensity of rehabilitation interventions on locomotor function, community mobility and quality of life in patients with subacute (1-6 months) post-stroke.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, you cannot receive physical therapy once baseline testing begins.
Is intensive walking therapy safe for stroke rehabilitation?
How is the Intensive Walking Therapy treatment different from other stroke rehabilitation treatments?
Intensive Walking Therapy is unique because it focuses on high-intensity, task-specific training, such as walking, which is designed to improve walking ability by incorporating a high cardiovascular workload and a large number of repetitions. This approach is different from standard physical therapy as it emphasizes early, intensive, and specific gait-oriented exercises to promote neural changes and improve motor function after a stroke.12346
Research Team
George Hornby
Principal Investigator
Indiana University
Eligibility Criteria
This trial is for individuals who had a stroke 1-6 months ago, can walk at least 10 meters with or without help but not faster than 1.0 m/s, and can follow simple commands. They must be able to sit unaided for over half a minute and have medical clearance to participate. People with severe heart issues, walking limitations before the stroke, or certain other health conditions cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 30 1-hour sessions of physical therapy interventions over approximately 2 months, focusing on varying intensities and task-specificity
Follow-up
Participants are monitored for changes in mobility function, gait speed, and quality of life after treatment
Treatment Details
Interventions
- High-intensity, non-specific physical therapy interventions
- High-intensity, task-specific (i.e., walking) interventions
- Low-intensity, non-specific physical therapy interventions
- Low-intensity, task-specific physical therapy interventions
High-intensity, non-specific physical therapy interventions is already approved in European Union, United States, Canada for the following indications:
- Stroke rehabilitation
- Locomotor function improvement
- Community mobility enhancement
- Subacute stroke rehabilitation
- Improvement of walking ability
- Enhancement of quality of life
- Post-stroke locomotor function recovery
- Community mobility improvement
- Quality of life enhancement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Northwestern University
Collaborator